New radiation drug targets Hard-to-Treat cancers in first human trial
NCT ID NCT05283330
First seen Jan 25, 2026 · Last updated Apr 30, 2026 · Updated 11 times
Summary
This early-stage study tests a new drug that delivers radiation directly to cancer cells with a specific marker (GRPR). It is for adults with advanced cancers like prostate, breast, lung, or colon cancer that have come back or spread. The main goals are to find a safe dose and check for early signs of tumor shrinkage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advanced Molecular Imaging and Therapy
RECRUITINGGlen Burnie, Maryland, 21061, United States
Contact Phone: •••-•••-••••
Contact
-
Northwestern University Robert H Lurie Medical Research
RECRUITINGChicago, Illinois, 60611, United States
Contact Email: •••••@•••••
Contact
-
UK Markey Cancer Center
RECRUITINGLexington, Kentucky, 40536, United States
Contact Phone: •••-•••-••••
Contact
-
XCancer Omaha / Urology Cancer Center
RECRUITINGOmaha, Nebraska, 68130, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.